The Middle East biobanks market size was estimated at USD 1.02 billion in 2025 and is predicted to increase from USD 1.09 billion in 2026 to approximately USD 1.9 billion by 2035, expanding at a CAGR of 6.44% from 2026 to 2035. Rising investment in precision medicine and genomic initiatives is expanding the market.

Middle East Biobanks Market Statical Scope

The term biobank refers to a collection of biological specimens, including DNA, RNA, tissues, and cells, linked in an informatics network to various information about the donor, such as biological, clinical, epidemiological features, and lifestyle. Biobanks are emerging throughout the Arab Middle East and have been established in several low- and middle-income countries (LMICs) and high-income countries (HICs) in the region. Notable examples include biobanks in Egypt, Jordan, and Sudan (LMICs), as well as those in Qatar and Saudi Arabia (HICs).

The growing adoption of personalized medicine and genomic research is a significant factor driving the biobanks market in the Middle East. Precision medicine requires access to high-quality, patient-specific biological samples and corresponding clinical data to develop therapies tailored to individual genetic profiles.

Middle East Biobanks Market Share, By Country, 2025

• The UAE biobanks market is poised for transformative growth, fueled by technological innovation and a shift toward personalized medicine. The UAE Genome Program, backed by G42 Healthcare and supported by national health authorities, aims to establish a reference genome for Emiratis, facilitating personalized healthcare for major diseases.

Middle East Biobanks Market Share, By Product, 2025, (%)

• Product- increased demand for biospecimen storage equipment and related products contributes to 55% share, establishes products as the leading segment in the Middle East biobanks market.
• Service- Growing need for sample collection, processing, storage services, and genetic sequencing contributes to segment growth and accounts for 45% share.

Middle East Biobanks Market Share, By Biospecimen, 2025, (%)

• Human tissues - Extensive use in research and therapeutic applications, with a 39% share, serves human tissues as the dominant biospecimen segment.
• Stem cells - this segment accounts for 25% share, driven by increasing demand for regenerative medicine and cell-based therapies.
• Human organs - the human organs segment holds 21% share as they are majorly used in transplant research and the study of regenerative medicine.
• Other Biospecimens - Includes various smaller applications, with a 15% share, result in limited overall contribution.

Middle East Biobanks Market Share, By Biobanks, 2025, (%)

• Physical/real biobanks- Established infrastructure and widespread adoption for sample storage accounts for 70% share, establishing physical biobanks as the dominant type.
• Virtual biobanks - swift adoption of digital platforms for management of biospecimen data and integration of AI accounts for 30% share.

Middle East Biobanks Market Share, By Application, 2025, (%)

• Therapeutics - the therapeutics segment holds 46% share. Strong demand for biospecimens in treatment development establishes therapeutics as the leading application segment.
• Drug discovery & clinical research- rising demand for bio samples for their application in drug tests and clinical research studies accounts for the 28% market share.
• Clinical diagnostics - the clinical diagnostics segment contributes for 18% share due to increasing demand for early disease detection, and personalized treatment planning.
• Other Applications -Includes various smaller applications, with a 8% share, result in limited overall contribution.

Top Companies in the Middle East Biobanks Market

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Qiagen
• Danaher Corporation
• Becton, Dickinson, and Company (BD)
• Taylor-Wharton
• Charles River Laboratories
• Lonza
• Stemcell Technologies
• Biovault Family

Segments Covered in the Report

By Product & Services

• Product
• Services

By Biospecimen

• Human Tissues
• Human Organs
• Stem Cells
• Other Biospecimens

By Biobanks

• Physical/Real Biobanks
• Virtual Biobanks

By Application

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics
• Other Applications